Guanosine triphosphate
|
Basic information |
| Metabolite name | Guanosine triphosphate |
 | HMDB0001273 |
 |
C00044 |
 |
6830 |
| Synonyms | Guanosine-5'-triphosphate; |
| No. of studies | 5 |
|
Basic information |
| Metabolite name | Guanosine triphosphate |
| HMDB0001273 |
|
C00044 |
|
6830 |
| Synonyms | Guanosine-5'-triphosphate; |
| No. of studies | 5 |
|
Relationship between Guanosine triphosphate and depression (count: 5) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M033 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Up |
| Study M050 | Type3 | 2h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Up |
| Study M664 | Type1 | CSDS group vs. control group | Hippocampus | C57BL/6 J mouse | Up |
| Study M664 | Type2 | CSDS + Dl-3-n-butylphthalide group vs. CSDS group | Hippocampus | C57BL/6 J mouse | Down |
| Study M762 | Type1 | corticosterone group vs. control group | Liver | Wistar rat | Up |
| Study M762 | Type2 | corticosterone + metformin group vs. corticosterone group | Liver | Wistar rat | Down |
| Study M885 | Type1 | CMS-vulnerable group vs. control group | Ventral hippocampus | Wistar rat | Up |